-
Establishment Labs Launches Motiva Breast Implants in China
•
Establishment Labs Holdings Inc., (NASDAQ: ESTA), a US-based medical technology company specializing in women’s health, has announced the official market launch of its Motiva brand breast implants in China. The company’s product line includes the Motiva Flora tissue expander, which is designed to enhance the outcomes of breast reconstruction post-breast…
-
Establishment Labs Receives NMPA Approval for Motiva Silicone Gel-Filled Breast Implants
•
US-based medical technology company Establishment Labs Holdings Inc., (NASDAQ: ESTA) has announced that it has received product approval from China’s National Medical Products Administration (NMPA) for its Motiva silicone gel-filled breast implants. This marks the company’s first approval in China, the world’s second-largest market for breast implants. Originally approved in…
